[The role of intestinal microbiota in the response to anti-tumor therapies]

Med Sci (Paris). 2016 Nov;32(11):974-982. doi: 10.1051/medsci/20163211013. Epub 2016 Dec 23.
[Article in French]

Abstract

The gut microbiota is involved in a lot of crucial physiological functions and maintains a symbiotic relationship with the host. Lately, in light of new evidences, an unexpected role of commensals has been depicted. Several studies addressing the role of gut microbiota in the immunomodulatory properties of anti-cancer regimens, such as immunotherapy and chemotherapy, reveal that commensals are required to mount complete and efficient antitumor immune responses. Therefore, exploration of microbiota-derived compounds in the future could represent a therapeutic option in the armamentarium of cancer treatments.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Biological Therapy / trends
  • Drug Resistance, Neoplasm
  • Dysbiosis / etiology
  • Gastrointestinal Microbiome* / drug effects
  • Gastrointestinal Microbiome* / immunology
  • Humans
  • Immunotherapy / adverse effects
  • Immunotherapy / methods
  • Neoplasms / complications
  • Neoplasms / drug therapy
  • Neoplasms / microbiology*
  • Neoplasms / therapy*
  • Treatment Outcome

Substances

  • Antineoplastic Agents